Global Drug Screening Market, By Product and Services (Equipment, Rapid Testing Devices (RTD), Consumables and Laboratory Services), Sample Type (Oral Fluid or Saliva, Breath, Hair, Urine, Other Samples), End User (Workplace and Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, and Pain Management Centers) – Industry Trends and Forecast to 2029.
Global Drug Screening Market Analysis and Size
Surging usage of drugs across the globe has accelerated drug screening adoption. According to the World Drug Report 2021, drug use disorders were estimated to affect 36.3 million people worldwide in 2019, accounting for nearly 13% of the global population. Drug use killed nearly half a million people in the same year and drug use disorders resulted in the loss of 18 million years of healthy life, primarily due to opioids. For subsiding the consumption of the drug, the stringent regulations are imposed widely. The market is projected to grow immensely over the forecasted period due to these factors.
- Global drug screening market was valued at USD 5.3 billion in 2021 and is expected to reach USD 18.99 billion by 2029, registering a CAGR of 17.3% during the forecast period of 2022-2029. The “urine” accounts for the largest sample type segment in the drug screening market within the forecasted period owing to the benefits it offers such as cost-effectiveness, high detection accuracy of multiple drugs and instant results. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Drug Screening Market Definition
Drug screening test basically analyses biological samples including blood, hair and urine; to diagnose the presence of drug abuse or its metabolites in patient’s body. Drug screening tests are used to determine whether or not a person is or was under the influence of drugs at any given time. Due to the introduction of new technology, providing users with precise and accurate results.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product and Services (Equipment, Rapid Testing Devices (RTD), Consumables and Laboratory Services), Sample Type (Oral Fluid or Saliva, Breath, Hair, Urine, Other Samples), End User (Workplace and Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, and Pain Management Centers)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
LabCorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens (Germany), F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (US), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics Corporation (US), Clinical Reference Laboratory Inc., (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), Sciteck, Inc. (US), Synens SAS (France), Intoximeters (US), AccuSource Inc., (US), Cordant Health Solutions (US), and Millennium Health (US)
|
Drug Screening Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
-
Growing Drugs Consumption
The rising consumption of illicit drugs is also expected to accelerate the market's overall growth as they further increase the adoption of drug screening products and services on the road. Moreover, the illegal drug use by teens will bolster the market growth.
Furthermore, the screening is easy to implement, thus offering flexible and effective workplace drug testing, which is also expected to fuel market growth. The increase in governmental funding to control drug trafficking is a significant factor that is projected to cushion the market's growth. The increasing road accidents due to overdose of drugs while driving and prescription drug misuse will further expand the drug screening market's growth rate in the future.
Restraints/Challenges Global Drug Screening Market
-
Prohibition of Drug Testing
The drug testing at some places (especially at workplace) is considered as a violation of employee privacy, which is expected to obstruct market growth.
The ban in consumption of drugs in certain places and accuracy issues related to breathalyzers are projected to challenge the drug screening market in the forecast period of 2022-2029.
Opportunities
-
Stringent Laws to Offer Growth Opportunities
Many economies have a stringent regulations against the usage or consumption of drugs. The enforcement of stringent laws mandating drug testing is estimated to generate lucrative opportunities for the market. Moreover, increasing usage of the fingerprint-based drug testing nowadays, has gained immense popularity, which is also estimated to offer various growth opportunities.
This drug screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Drug Screening Market
The drug screening market was largely industry impacted by the outbreak of COVID-19. Imposition of the lockdown and social distancing restrictions by the government in travel, public gatherings, business operations, and shelter-in-place orders to curb the COVID-19 pandemic outbreak, led to limited or non-availability of medical facilities/treatment centers and also halt in various operations, reduced demand and supply chain disruptions, limiting the industry's expansion. Postponement of non-essential medical services amid the covid-19 outbreak also affected the growth of the drug screening market. The trade barriers have further negatively impacted the demand-supply gap.
With a gradual decrease in the disease, the restrictions are likely to relax and the various operations will continue, which will help the market witness a slight increment post COVID-19.
Recent Developments
- In August 2021, Select Health of South Carolina and Quest Diagnostics have reached an agreement to expand Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees and improve members' access diagnostics information services.
Global Drug Screening Market Scope
The drug screening market is segmented on the basis of product and services, sample type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Equipment
- Rapid Testing Devices (RTD)
- Consumables
- Laboratory Services
On the basis of product and services, the drug screening market is segmented into equipment, rapid testing devices (RTD), consumables and laboratory services. Equipment is further sub segmented into immunoassay analyzers, chromatography instruments, and breath analyzers. Breath analyzers is further sub segmented into semiconductor breath analyzers and fuel cell analyzers. Rapid testing devices (RTD) is further sub segmented into oral fluid testing devices and urine testing devices. Consumables is further sub segmented into assay kits, calibrators and controls, and sample collection cups.
Sample Type
- Oral Fluid or Saliva
- Breath
- Hair
- Urine
- Other Samples
On the basis of sample type, the drug screening market is segmented into oral fluid or saliva, breath, hair, urine and other samples. Urine sample is projected to dominate the market owing to the benefits it offers such as cost-effectiveness, high detection accuracy of multiple drugs and instant results.
End User
- Workplace and Schools
- Criminal Justice Systems and Law Enforcement Agencies
- Drug Testing Laboratories
- Drug Treatment Centers
- Hospitals
- Personal Users
- Pain Management Centers
On the basis of end user, the drug screening market is bifurcated into workplace and schools, criminal justice systems and law enforcement agencies, drug testing laboratories, drug treatment centers, hospitals, personal users and pain management centers.
Drug Screening Market Regional Analysis/Insights
The drug screening market is analyzed and market size insights and trends are provided by country, product and services, sample type and end user as referenced above.
The countries covered in the drug screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the drug screening market because of the increasing ingesting of illegal drugs, accessibility of government backing to control drug abuse and the existence of rules encouraging drug screening within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the existence of top market players, the expansion in research and development services, accessible disposable income and promptly creating economic circumstances within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The drug screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug screening market. The data is available for historic period 2010-2020.
Competitive Landscape and Drug Screening Market Share Analysis
The drug screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to drug screening market.
Some of the major players operating in the drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens (Germany), F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (US), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics Corporation (US), Clinical Reference Laboratory Inc., (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), Sciteck, Inc. (US), Synens SAS (France), Intoximeters (US), AccuSource Inc., (US), Cordant Health Solutions (US), and Millennium Health (US) among others.
Research Methodology : Global Drug Screening Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-drug-screening-market
SKU-